Then, we assessed the expression levels of PRKAR1A and E-cadherin proteins in the same 102 lung adenocarcinoma specimens by immunohistochemistry (Fig. 4C, Figure S4). This evidence concerns the gene PRKAR1A and lung adenocarcinoma.